Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Update on offer for subscription

14 Aug 2020 14:36

RNS Number : 2272W
Amati AIM VCT PLC
14 August 2020
 

14 August 2020

 

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

Update on offer for subscription

The Board of Amati AIM VCT plc (the "Company") announced on 31 October 2019 that the Company had published a prospectus in connection with proposals to raise up to £25,000,000 (with an over-allotment facility to raise up to a further £20,000,000), by way of an offer for subscription (the "Offer") of new ordinary shares (the "New Shares").

The Company announced on 29 April 2020 that £25,000,000 had been raised under the Offer and that the Board had decided not to utilise the over-allotment facility at that time. However, the Company has continued to identify and make new investments, with around £11.4 million new qualifying investments being made since the start of the Company's financial year on 1 February 2020.

Having considered the current rate of investment activity, the Board is pleased to announce that the Offer has now re-opened and the Company is seeking to raise up to £20,000,000 available under the over-allotment facility. The next allotment of New Shares under the Offer is expected to be on or around 14 September 2020 and thereafter allotments will be made at the discretion of the Board. The Offer will close at 12 noon on 16 October 2020 (unless the Offer is fully subscribed before this date and/or the Board closes the Offer earlier, which it may do in its sole discretion).

The Prospectus is available at www.amatiglobal.com and https://data.fca.org.uk/#/nsm/nationalstoragemechanism and, until 30 October 2020, copies are available for collection, free of charge, from the offices of Amati Global Investors and the offices of Dickson Minto W.S. on any Business Day. Copies can also be requested by contacting Amati Global Investors on +44 (0)131 503 9115 or by email at info@amatiglobal.com.

Subscriptions can be made online at www.amatioffer.com or by completing the subscription form contained in the Prospectus.

For further information, please contact Samantha Dalby on +44 (0)131 503 9115 or email: info@amatiglobal.com

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations ((EU) No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
OUPEADPLFDLEEFA
Date   Source Headline
1st Feb 20234:33 pmRNSNet Asset Value(s)
1st Feb 202311:00 amRNSTotal Voting Rights
27th Jan 20233:16 pmRNSNet Asset Value(s)
20th Jan 20234:54 pmRNSTransaction in Own Shares
20th Jan 20233:03 pmRNSNet Asset Value(s)
20th Jan 202310:54 amRNSDirector/PDMR Shareholding
13th Jan 20233:27 pmRNSNet Asset Value(s)
6th Jan 20233:53 pmRNSNet Asset Value(s)
6th Jan 202311:42 amRNSTransaction in Own Shares
3rd Jan 20234:49 pmRNSNet Asset Value(s)
3rd Jan 20239:33 amRNSTotal Voting Rights
23rd Dec 202210:53 amRNSNet Asset Value(s)
22nd Dec 20224:15 pmRNSTransaction in Own Shares
16th Dec 20222:27 pmRNSNet Asset Value(s)
9th Dec 20224:52 pmRNSNet Asset Value(s)
6th Dec 20224:44 pmRNSTransaction in Own Shares
1st Dec 20224:52 pmRNSNet Asset Value(s)
1st Dec 20224:39 pmRNSBoard Committee Change
1st Dec 20224:19 pmRNSTotal Voting Rights
28th Nov 202210:35 amRNSDirector/PDMR Shareholding
25th Nov 20224:56 pmRNSIssue of Equity - DRIS
25th Nov 20223:29 pmRNSNet Asset Value(s)
21st Nov 20222:52 pmRNSTransaction in Own Shares
18th Nov 20224:15 pmRNSNet Asset Value(s)
11th Nov 20223:42 pmRNSNet Asset Value(s)
4th Nov 20222:40 pmRNSNet Asset Value(s)
1st Nov 20225:32 pmRNSNet Asset Value(s)
1st Nov 202210:06 amRNSTotal Voting Rights
24th Oct 202210:45 amRNSNet Asset Value(s)
21st Oct 20223:09 pmRNSTransaction in Own Shares
17th Oct 202212:04 pmRNSNet Asset Value(s)
12th Oct 20225:19 pmRNSTransaction in Own Shares
10th Oct 20222:40 pmRNSNet Asset Value(s)
4th Oct 20221:50 pmRNSNet Asset Value(s)
3rd Oct 20229:16 amRNSTotal Voting Rights
30th Sep 20227:01 amRNSDividend Declaration
30th Sep 20227:00 amRNSHalf-year Report
28th Sep 20223:02 pmRNSTransaction in Own Shares
23rd Sep 20224:09 pmRNSNet Asset Value(s)
23rd Sep 20223:56 pmRNSTransaction in Own Shares
22nd Sep 202210:53 amRNSTransaction in Own Shares
16th Sep 20225:19 pmRNSNet Asset Value(s)
13th Sep 20223:10 pmRNSCancellation of Share Premium Account
9th Sep 20223:02 pmRNSNet Asset Value(s)
7th Sep 20221:56 pmRNSTransaction in Own Shares
2nd Sep 202210:40 amRNSReplacement Total Voting Rights
1st Sep 20225:08 pmRNSTotal Voting Rights
1st Sep 20224:26 pmRNSTransaction in Own Shares
1st Sep 20223:48 pmRNSNet Asset Value(s)
30th Aug 20224:14 pmRNSCompliance with Market Abuse Regulation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.